IDEAYA Biosciences Appoints New Director, Adjusts Executive Pay
Ticker: IDYA · Form: 8-K · Filed: Jun 27, 2025 · CIK: 1676725
| Field | Detail |
|---|---|
| Company | Ideaya Biosciences, Inc. (IDYA) |
| Form Type | 8-K |
| Filed Date | Jun 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, board-changes, employment-agreement
Related Tickers: IDYA
TL;DR
IDEAYA adds a director, boosts exec pay for Nakagawa & Park.
AI Summary
IDEAYA Biosciences, Inc. announced on June 26, 2025, changes in its board of directors and executive compensation. Specifically, Dr. Paul R. Hastings was appointed as a new director, and the company entered into new employment agreements with its Chief Executive Officer, Yujiro S. Nakagawa, and Chief Medical Officer, Dr. David M. Park. These agreements detail base salaries, potential bonuses, and equity awards.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, and future performance expectations.
Risk Assessment
Risk Level: medium — Changes in executive compensation and board appointments can indicate strategic shifts or potential future performance pressures.
Key Numbers
- 650-443-6209 — Registrant's telephone number (Contact information for IDEAYA Biosciences, Inc.)
Key Players & Entities
- IDEAYA Biosciences, Inc. (company) — Registrant
- Dr. Paul R. Hastings (person) — Appointed Director
- Yujiro S. Nakagawa (person) — Chief Executive Officer
- Dr. David M. Park (person) — Chief Medical Officer
- June 26, 2025 (date) — Date of earliest event reported
FAQ
Who was appointed as a new director for IDEAYA Biosciences, Inc.?
Dr. Paul R. Hastings was appointed as a new director.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is June 26, 2025.
What are the key executive positions mentioned in relation to new employment agreements?
The key executive positions are Chief Executive Officer (Yujiro S. Nakagawa) and Chief Medical Officer (Dr. David M. Park).
What is the principal executive office address of IDEAYA Biosciences, Inc.?
The address is 5000 Shoreline Court, Suite 300, South San Francisco, California 94080.
What is the Commission File Number for IDEAYA Biosciences, Inc.?
The Commission File Number is 001-38915.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 27, 2025 by Dr. Paul R. Hastings regarding IDEAYA Biosciences, Inc. (IDYA).